https://www.marketscreener.com/quote/stock/HOOKIPA-PHARMA-INC-57291650/news/HOOKIPA-Pharma-Phase-1-HB-200-data-show-unprecedented-T-cell-response-favorable-tolerability-and-35541917/?utm_source=telegram&utm_medium=social&utm_campaign=share